BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23077236)

  • 21. SUMO2/3 modification of activating transcription factor 5 (ATF5) controls its dynamic translocation at the centrosome.
    Yuan Y; Gaither K; Kim E; Liu E; Hu M; Lengel K; Qian D; Xu Y; Wang B; Knipprath H; Liu DX
    J Biol Chem; 2018 Feb; 293(8):2939-2948. PubMed ID: 29326161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis.
    Namanja AT; Li YJ; Su Y; Wong S; Lu J; Colson LT; Wu C; Li SS; Chen Y
    J Biol Chem; 2012 Jan; 287(5):3231-40. PubMed ID: 22147707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ubiquitination and sumoylation of acrosin inhibitor during in vitro capacitation of porcine sperm.
    Chen X; Liang W; Wang S; Lv Y; Han Y; Xu D; Jin Y
    Anim Biotechnol; 2021 Oct; 32(5):646-655. PubMed ID: 34554078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
    Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
    J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation Landscape of Renal Cortical Collecting Duct Cells.
    Wu Q; Aroankins TS; Cheng L; Fenton RA
    J Proteome Res; 2019 Oct; 18(10):3640-3648. PubMed ID: 31502464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the tumor suppressor PTEN by SUMO.
    González-Santamaría J; Campagna M; Ortega-Molina A; Marcos-Villar L; de la Cruz-Herrera CF; González D; Gallego P; Lopitz-Otsoa F; Esteban M; Rodríguez MS; Serrano M; Rivas C
    Cell Death Dis; 2012 Sep; 3(9):e393. PubMed ID: 23013792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression, Localization of SUMO-1, and Analyses of Potential SUMOylated Proteins in
    Brohi RD; Wang L; Hassine NB; Cao J; Talpur HS; Wu D; Huang CJ; Rehman ZU; Bhattarai D; Huo LJ
    Front Physiol; 2017; 8():354. PubMed ID: 28659810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the SUMOylated landscape.
    Eifler K; Vertegaal AC
    FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sumo-dependent substrate targeting of the SUMO protease Ulp1.
    Elmore ZC; Donaher M; Matson BC; Murphy H; Westerbeck JW; Kerscher O
    BMC Biol; 2011 Oct; 9():74. PubMed ID: 22034919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO modifies GβL and mediates mTOR signaling.
    Park SLL; Ramírez-Jarquín UN; Shahani N; Rivera O; Sharma M; Joshi PS; Hansalia A; Dagar S; McManus FP; Thibault P; Subramaniam S
    J Biol Chem; 2024 Apr; 300(4):105778. PubMed ID: 38395307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-specific characterization of endogenous SUMOylation across species and organs.
    Hendriks IA; Lyon D; Su D; Skotte NH; Daniel JA; Jensen LJ; Nielsen ML
    Nat Commun; 2018 Jun; 9(1):2456. PubMed ID: 29942033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
    Gareau JR; Lima CD
    Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
    Su HL; Li SS
    Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SUMOylated Golgin45 associates with PML-NB to transcriptionally regulate lipid metabolism genes during heat shock stress.
    Jing S; Gao J; Tiwari N; Du Y; Zhu L; Gim B; Qian Y; Yue X; Lee I
    Commun Biol; 2024 May; 7(1):532. PubMed ID: 38710927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
    Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
    Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SUMO-1, human male germ cell development, and the androgen receptor in the testis of men with normal and abnormal spermatogenesis.
    Vigodner M; Ishikawa T; Schlegel PN; Morris PL
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1022-33. PubMed ID: 16352666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.